Abstract:Medical progress has historically depended on scientific discoveries. Until recently, science was driven by technological advancements that, once translated to the clinic, fostered new treatments and interventions. More recently, technology-driven medical progress has often outpaced laboratory research. For example, intravascular devices, pacemakers for the heart and brain, spinal cord stimulators, and surgical robots are used routinely to treat a variety of diseases. The rapid expansion of science into ever more advanced molecular and genetic mechanisms of disease has often distanced laboratory-based research from day-to-day clinical realities that remain based on evidence and outcomes. A recognized reason for this hiatus is the lack of laboratory tools that recapitulate the clinical reality faced by physicians and surgeons. To overcome this, the NIH and FDA have in the recent past joined forces to support the development of a "human-on-a-chip" that will allow research scientists to perform experiments on a realistic replica when testing the effectiveness of novel experimental therapies. The development of a "human-on-a-chip" rests on the capacity to grow in vitro various organs-on-a-chip, connected with appropriate vascular supplies and nerves, and our ability to measure and perform experiments on these virtually invisible organs. One of the tissue structures to be scaled down on a chip is the human blood-brain barrier. This review gives a historical perspective on in vitro models of the BBB and summarizes the most recent 3D models that attempt to fill the gap between research modeling and patient care. We also present a summary of how these in vitro models of the BBB can be applied to study human brain diseases and their treatments. We have chosen NeuroAIDS, COVID-19, multiple sclerosis, and Alzheimer's disease as examples of in vitro model application to neurological disorders. Major insight pertaining to these illnesses as a consequence of more profound understanding of the BBB can reveal new avenues for the development of diagnostics, more efficient therapies, and definitive clarity of disease etiology and pathological progression.

Vascularizing the brain <i>in vitro</i>

Engineering Three-Dimensional Microenvironments Towards in Vitro Disease Models of the Central Nervous System

Anatomically and Physiologically Accurate Engineered Neurovascular Unit and Blood-Brain Barrier Model Using Microvessels Isolated from Postmortem Human Brain Tissue

Functional Blood-Brain Barrier Model with Tight Connected Minitissue by Liquid Substrates Culture.

Vascularized neural constructs for ex-vivo reconstitution of blood-brain barrier function

Engineering Neurovascular Unit and Blood‐Brain Barrier for Ischemic Stroke Modeling

In vitro Models of the Blood-Brain Barrier: Tools in Translational Medicine

Cell-culture models of the blood-brain barrier.

Generation of Vascularized Brain Organoids to Study Neurovascular Interactions

3D brain angiogenesis model to reconstitute maturation of functional human blood-brain barrier in vitro

Paving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells

Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug Development

3D hydrogel models of the neurovascular unit to investigate blood-brain barrier dysfunction

Experimental Models to Study the Functions of the Blood–Brain Barrier

Angiorganoid: Vitalizing the Organoid with Blood Vessels.

An in Vivo Model of Functional and Vascularized Human Brain Organoids.

In vitro modelling of the neurovascular unit for ischemic stroke research: Emphasis on human cell applications and 3D model design

An In Vitro Model of the Blood-Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis

Engineering microcapsules to construct vascularized human brain organoids

Recent Progress in Microfluidic Models of the Blood-Brain Barrier

Current progress and challenges in the development of brain tissue models: How to grow up the changeable brain in vitro?